XML 25 R15.htm IDEA: XBRL DOCUMENT v3.7.0.1
Share-Based Payments (Tables)
3 Months Ended
Jul. 31, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Allocation of Share Based Compensation Expense
Stock-based compensation expense was recognized as follows (table in thousands):
 
 
Three Months Ended
July 31,
 
2017
 
2016
General and administrative
$
423

 
$
830

Sales and marketing
34

 
168

Research and development
80

 
85

TOS cost of sales
26

 
44

POS cost of sales
1

 
2

Total stock-based compensation expense
$
564

 
$
1,129

Valuation Assumptions for Stock Options
Black-Scholes assumptions used to calculate the fair value of options granted during the three months ended July 31, 2017 and 2016 were as follows:
 
 
Three Months Ended
July 31,
 
2017
 
2016
Expected term in years
6
 
2.6 - 6
Risk-free interest rates
1.98%
 
0.75% - 1.25%
Volatility
87.1%
 
73.2% - 95.6%
Dividend yield
—%
 
—%
Summary of Stock Option Activity
The Company’s stock options activity for the three months ended July 31, 2017 was as follows:
 
 
Non-
Employees
 
Directors
and
Employees
 
Total
 
Weighted
Average
Exercise
Price
 
Weighted
Average
Remaining
Contractual
Life (Years)
 
Aggregate
Intrinsic
Value
Outstanding, May 1, 2017
50,000

 
2,258,704

 
2,308,704

 
$
2.86

 
6.1
 
$
1,282,000

Granted

 
194,977

 
194,977

 
2.51

 

 


Exercised

 

 

 

 
 
 
 

Forfeited

 
(1,875
)
 
(1,875
)
 
7.76

 
 
 
 

Canceled

 

 

 

 
 
 
 
Expired

 

 

 

 
 
 
 

 
 
 
 
 
 
 
 
 
 
 
 
Outstanding, July 31, 2017
50,000

 
2,451,806

 
2,501,806

 
2.83

 
6.1
 
$
1,720,000

 
 
 
 
 
 
 
 
 
 
 
 
Vested and expected to vest as of July 31, 2017
50,000

 
2,451,806

 
2,501,806

 
2.83

 
6.1
 
$
1,720,000

 
 
 
 
 
 
 
 
 
 
 
 
Exercisable as of July 31, 2017
33,336

 
2,287,095

 
2,320,431

 
2.85

 
6.0
 
$
1,608,000

Summary of Warrant Activity
Activity related to these warrants, which expire at various dates through March 2020, is summarized as follows:
 
Number
of
Shares
 
Weighted
Average
Exercise
Price
 
Weighted
Average
Remaining
Contractual
Life (Years)
 
Aggregate
Intrinsic
Value
Outstanding, May 1, 2017
2,004,284

 
$
5.57

 
2.8

 
$

Granted

 

 

 

Exercised

 

 

 

Expired

 

 

 

 
 
 
 
 
 
 
 
Outstanding, July 31, 2017
2,004,284

 
$
5.57

 
2.5

 
$